A wide variety of activities are spelled out in the Masterplan, aiming at a sustainable drug supply infrastructure for Tanzania, particularly for its public health sector.
Within the Ministry of Health a newly established Pharmaceuticals and Supplies Unit will be the responsible public sector drug supply management authority. Actual public sector drug procurement and distribution will be the responsibility of an autonomous Central Medical Stores, restructured and strengthened by establishing Regional Medical Stores. The EDP kit system will be replaced by a requisition based drug supply system: each health facility will have to requisition its drug requirements from the Regional Medical Store on a cash-and-carry basis and within the limits of the available budget. The Pharmaceuticals and Poisons Act (1978) will be replaced by an effective new Act and the competent drug regulatory authority, the Pharmacy Board, will be strengthened.
Drug registration will become mandatory for all drugs moving in the Tanzanian Market and will be implemented by the Drug Registration Unit of the Board. The responsibilities and capabilities of the Drug Inspection Unit of the Board will be expanded.
The capacity to train pharmaceutical manpower will increase to improve on overall drug management.
The local Pharmaceutical industry will be given an opportunity to meet the quality requirements of the local Tanzanian Good Manufacturing Practise for drugs. The industry will be enabled to better compete for the delivery of drugs to the public sector through CMS.
The role of traditional medicine in the provision of health care will be expanded; safe and effective herbal medicines will be made easier accessible and available.
Drug related cost sharing systems will be considered for implementation to improve on the availability of essential drugs in health facilities.